Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. (ARMP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
armp · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$15.00
+96.7% upside
Low
$15.00
Median: $15 · Last Close: $7.63
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.26 | ↓ 4.84% |
1-day model range: $7.16–$7.35. Peak: $7.35 (-4.84%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ARMP · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Armata Pharmaceuticals, Inc. (ARMP) stock. Of the recent 20 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover ARMP.
Analyst Recommendation Trends
ARMP analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 96.1% YoY
Revenue Next Year
$3M
↑ 25.0% YoY
EPS This Year
$-3.81
EPS Next Year
$-1.34
↓ 64.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast ARMP EPS of $-3.81 for the current fiscal year, based on estimates from 1 analysts. The ARMP revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ARMP stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ARMP price target is $15.00 (+96.7% upside), with an analyst consensus of Buy.
The ARMP short-term stock prediction for tomorrow is $7.26 (-4.84%).
Armata Pharmaceuticals, Inc. trades on AMEX under the ticker ARMP. The ARMP stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ARMP forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month ARMP price target is $15.00, with a high forecast of $15.00 and a low of $15.00. The median price target is shown in the chart above when available. This implies +96.7% potential upside from the current price of $7.63.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.